NDC 50090-1083
Benicar HCT
Olmesartan Medoxomil-hydrochlorothiazide
Benicar HCT is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Olmesartan Medoxomil; Hydrochlorothiazide.
| Product ID | 50090-1083_6e114be5-3209-4dfa-88c3-05ed7d6b37e3 |
| NDC | 50090-1083 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Benicar HCT |
| Generic Name | Olmesartan Medoxomil-hydrochlorothiazide |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2003-06-05 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021532 |
| Labeler Name | A-S Medication Solutions |
| Substance Name | OLMESARTAN MEDOXOMIL; HYDROCHLOROTHIAZIDE |
| Active Ingredient Strength | 40 mg/1; mg/1 |
| Pharm Classes | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
Packaging
NDC 50090-1083-0
30 TABLET, FILM COATED in 1 BOTTLE (50090-1083-0)
| Marketing Start Date | 2014-11-28 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 50090-1083-0 [50090108300]
Benicar HCT TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA021532 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2014-11-28 |
| Marketing End Date | 2019-10-31 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| OLMESARTAN MEDOXOMIL | 40 mg/1 |
Pharmacological Class
- Angiotensin 2 Receptor Antagonists [MoA]
- Angiotensin 2 Receptor Blocker [EPC]
- Increased Diuresis [PE]
- Thiazide Diuretic [EPC]
- Thiazides [CS]
NDC Crossover Matching brand name "Benicar HCT" or generic name "Olmesartan Medoxomil-hydrochlorothiazide"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0713-0863 | Benicar HCT | olmesartan medoxomil-hydrochlorothiazide |
| 0713-0864 | Benicar HCT | olmesartan medoxomil-hydrochlorothiazide |
| 0713-0865 | Benicar HCT | olmesartan medoxomil-hydrochlorothiazide |
| 50090-1083 | Benicar HCT | olmesartan medoxomil-hydrochlorothiazide |
| 55289-443 | Benicar HCT | olmesartan medoxomil-hydrochlorothiazide |
| 65597-105 | Benicar HCT | olmesartan medoxomil-hydrochlorothiazide |
| 65597-106 | Benicar HCT | olmesartan medoxomil-hydrochlorothiazide |
| 65597-107 | Benicar HCT | olmesartan medoxomil-hydrochlorothiazide |
| 50090-4329 | Olmesartan Medoxomil and Hydrochlorothiazide | olmesartan medoxomil-hydrochlorothiazide |
| 57664-758 | Olmesartan Medoxomil and Hydrochlorothiazide | olmesartan medoxomil-hydrochlorothiazide |
| 57664-759 | Olmesartan Medoxomil and Hydrochlorothiazide | olmesartan medoxomil-hydrochlorothiazide |
| 57664-760 | Olmesartan Medoxomil and Hydrochlorothiazide | olmesartan medoxomil-hydrochlorothiazide |
| 71335-0203 | Olmesartan Medoxomil and Hydrochlorothiazide | olmesartan medoxomil-hydrochlorothiazide |
Trademark Results [Benicar HCT]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 BENICAR HCT 78323613 2928799 Live/Registered |
DAIICHI SANKYO COMPANY, LIMITED 2003-11-05 |
 BENICAR HCT 78308053 not registered Dead/Abandoned |
SANKYO COMPANY LIMITED 2003-10-01 |
 BENICAR HCT 78138481 2867773 Live/Registered |
DAIICHI SANKYO COMPANY, LIMITED 2002-06-25 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.